# Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B

> **NCT06618079** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Huons Co., Ltd.** · enrollment: 46 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** HUC2-565-A, HUC2-565-A and HUC2-565-B
- **DRUG:** HUC2-565-B, HUC2-565-A and HUC2-565-B

## Key facts

- **NCT ID:** NCT06618079
- **Lead sponsor:** Huons Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-20
- **Primary completion:** 2024-07-12
- **Final completion:** 2024-10-01
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06618079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06618079, "Drug-Drug Interaction Study Between HUC2-565-A and HUC2-565-B". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06618079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*